Hidradenitis suppurativa

L12_HIDRADENITISSUP

hidradenitis suppurativa: a common (though rarely diagnosed), chronic skin disease characterized by clusters of abscesses or subcutaneous boil-like "infections" (oftentimes free of actual bacteria) that most commonly affects apocrine sweat gland bearing areas, such as the underarms, under the breasts, inner thighs, groin and buttocks.The disease is not contagious. There are indications that it is hereditary among certain ethnic groups and autoimmune in nature. Onset is most common in the late teens and early 20's.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L73.2 Hospital discharge: ICD-9 — 7058C Cause of death: ICD-10 — L73.2 Cause of death: ICD-9 — 7058C 2 out of 7 registries used, show all original rules.	1513
4. Check minimum number of events None	1513
5. Include endpoints None	1513
6. Filter based on genotype QC (FinnGen only)	1453

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L73
Name in latin: Hidradenitis suppurativa

NAME	L12_HIDRADENITISSUP
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L732
HD_ICD_9	7058C
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L732
COD_ICD_9	7058C
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hidradenitis suppurativa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7919	4721	3160
Only index persons	7639	4620	3019
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.15	0.17	0.12
Median age at first event (years)
Whole population	38.04	36.15	40.86
Only index persons	37.79	36.01	40.52

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1453	1008	445
Unadjusted period prevalence (%)	0.31	0.36	0.20
Median age at first event (years)	40.93	38.38	46.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1513: Matched controls
15130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01FF01

ATC

clindamycin; systemic

7.9

307.7

918

2481

S10

ICPC

Boil/carbuncle

19.0

307.7

498

380

J01AA04

ATC

lymecycline; systemic

7.8

307.7

638

1299

L73.2

ICD-10 Finland

Hidradenitis suppurativa

15511.4

307.7

1454

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

16.5

307.7

299

223

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

20.6

307.7

433

289

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

19.4

284.0

232

140

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

14.3

271.0

264

220

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

9.5

248.7

332

433

J04BA02

ATC

dapsone; oral

85.1

236.0

125

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

11.0

235.6

274

297

J01AA07

ATC

tetracycline; systemic

5.6

221.1

599

1596

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

17.7

212.1

179

114

L72.1

ICD-10 Finland

Trichilemmal cyst

10.1

210.3

259

302

D05BB02

ATC

acitretin; oral

18.5

181.0

148

D10BA01

ATC

isotretinoin; oral

6.3

174.9

346

681

SPAT1148

SPAT

Treatment of chronic ulcer or burn

6.2

173.2

346

687

L70.0

ICD-10 Finland

Acne vulgaris

12.9

170.6

172

149

QBA10

NOMESCO Finland

Incision of skin of trunk

28.9

155.3

105

J04AB02

ATC

rifampicin; systemic

25.6

148.7

105

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

7.0

136.9

227

370

A10BA02

ATC

metformin; oral

3.9

134.0

550

1915

QBE05

NOMESCO Finland

Excision of sweat glands or sweat gland bearing skin from trunk

1336.7

128.1

123

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

13.5

122.6

118

S97

ICPC

Chronic ulcer skin

7.9

115.9

169

238

L73.8

ICD-10 Finland

Other specified follicular disorders

34.9

110.3

L04AB04

ATC

adalimumab; parenteral

8.8

107.3

141

175

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

16.0

105.8

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

+∞

105.5

100

XQ848

NOMESCO Finland

Dermatological photography

11.0

100.3

110

107

7058C

ICD-9 Finland

Disorders of sweat glands, Other specified disorders of sweat glands[HIDRADENITIS SUPPURATIVA]

+∞

98.0

SPAT1146

SPAT

Puncture of abscess or incision of skin

12.3

94.6

P01AB01

ATC

metronidazole; oral, rectal

3.0

94.1

838

4450

TQW80

NOMESCO Finland

Local dermatologic skincare

10.7

92.9

104

E66.01

ICD-10 Finland

Obesity due to excess calories

3.9

89.9

310

931

J01CF05

ATC

flucloxacillin; systemic

5.1

89.4

204

445

N07BA03

ATC

varenicline; oral

5.5

89.2

189

386

J01DB01

ATC

cefalexin; oral

8.8

86.3

1451

11004

S18

ICPC

Laceration/cut

2.8

86.2

788

4185

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.7

86.1

144

234

103

Kela drug reimbursment

Diabetes, insulin-treated

3.2

82.9

438

1719

E0000UV, ,

ATC

2.8

81.4

811

4462

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.2

80.6

427

1676

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.3

79.2

367

1328

K61.0

ICD-10 Finland

Anal abscess

9.8

78.8

100

T90

ICPC

Diabetes non-insulin dependent

3.2

75.8

381

1444

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

10.8

74.4

J01DA01

ATC

[U] cefalexin

2.9

71.8

1107

7391

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.8

71.5

248

741

E66.8

ICD-10 Finland

Other obesity

4.3

69.2

195

501

N02AX02

ATC

tramadol; systemic, rectal

2.5

67.0

716

3965

S76

ICPC

Skin infection other

5.3

65.1

140

288

ZZR00

NOMESCO Finland

Flap of skin

10.6

61.2

D06AX01

ATC

fusidic acid; topical

3.4

60.6

247

816

K60.3

ICD-10 Finland

Anal fistula

8.5

60.3

J01DA09

ATC

[U] cefadroxil

2.5

59.3

535

2705

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

3.1

59.2

299

1123

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

8.8

58.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

58.3

245

824

N76.4

ICD-10 Finland

Abscess of vulva

14.6

56.4

T82

ICPC

Obesity

4.5

53.9

140

336

D07AD01

ATC

clobetasol; topical

2.8

53.9

318

1296

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

12.1

53.4

S29

ICPC

Skin symptom/complaint other

2.7

53.1

359

1568

SPAT1262

SPAT

Handing over of treatment supplies

2.9

53.1

292

1145

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

52.5

645

3693

J01MA02

ATC

ciprofloxacin; systemic

2.3

52.4

601

3342

H02AB06

ATC

prednisolone; systemic

2.3

51.9

773

4787

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.2

50.8

229

800

TQW99

NOMESCO Finland

Other minor procedure on skin

5.3

50.4

106

213

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

50.0

172

506

N05AH04

ATC

quetiapine; oral

2.5

50.0

401

1896

C03CA01

ATC

furosemide; systemic

2.8

49.4

292

1187

S04

ICPC

Lump/swelling localized

3.1

49.3

239

871

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.8

48.5

158

448

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.4

48.4

128

311

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.0

47.5

143

383

A46

ICD-10 Finland

Erysipelas

3.1

47.1

225

812

J01MA12

ATC

levofloxacin; systemic

2.7

47.0

296

1240

SPAT1263

SPAT

Sampling

2.2

46.6

728

4534

SPAT1260

SPAT

Consultation of another employee

2.6

45.6

323

1433

G47.3

ICD-10 Finland

Sleep apnoea

2.4

45.6

396

1932

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

5.6

44.4

164

E66.00

ICD-10 Finland

Metabolic syndrome

4.0

44.3

133

355

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

6.7

44.1

110

C03DA01

ATC

spironolactone; oral

3.4

43.9

168

529

JHA00

NOMESCO Finland

Anal or perianal incision

7.5

42.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.9

42.5

130

352

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

42.4

734

4700

N06AX11

ATC

mirtazapine; oral

2.1

42.3

587

3459

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.4

41.5

163

521

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

11.6

41.5

D07AC01

ATC

betamethasone; topical

2.1

41.5

587

3479

D95

ICPC

Anal fissure/perianal abscess

9.9

41.4

L70.1

ICD-10 Finland

Acne conglobata

113.2

40.9

J01AA02

ATC

doxycycline; systemic

2.3

40.5

1187

9209

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

40.4

323

1509

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

40.0

178

614

N03AX16

ATC

[U] pregabalin

2.3

39.9

371

1853

L40.0

ICD-10 Finland

Psoriasis vulgaris

4.4

39.5

102

243

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

39.4

125

347

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

7.5

38.7

N02BE01

ATC

paracetamol; systemic, rectal

3.1

38.2

1376

11533

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

9.1

37.3

A02BC02

ATC

pantoprazole; systemic

2.1

37.3

1006

7425

S92

ICPC

Sweat gland disease

194.8

36.9

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

12.7

36.7

A10BJ06

ATC

semaglutide; parenteral

3.8

36.1

114

315

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

36.0

303

1443

N06AB04

ATC

citalopram; systemic

2.2

35.8

370

1920

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

35.6

240

1031

SPAT1301

SPAT

No procedures

2.1

35.5

482

2780

Z72.0

ICD-10 Finland

Tobacco use

4.9

34.9

165

L70.8

ICD-10 Finland

Other acne

52.6

34.6

9733

FHL

Excision of skin change in operating room or anesthesia

7.6

34.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.4

34.5

216

N06AX12

ATC

bupropion; oral

2.7

34.3

205

829

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.2

34.2

361

1885

N05BA04

ATC

oxazepam; oral

2.1

34.2

439

2473

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

34.1

722

4846

M79.6

ICD-10 Finland

Pain in limb

1.9

33.9

669

4382

R02

ICPC

Shortness of breath/dyspnoea

2.7

33.7

209

860

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

33.7

328

1657

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

33.5

894

6463

D05AX52

ATC

calcipotriol, combinations; topical

3.8

33.4

108

303

E66.9

ICD-10 Finland

Obesity, unspecified

3.8

33.3

104

285

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.6

33.3

215

903

D07XC01

ATC

betamethasone; topical

2.7

32.8

201

822

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.2

32.7

356

1878

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.2

32.4

136

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.6

32.4

114

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

32.3

708

4777

D10AF01

ATC

clindamycin; topical

3.2

32.1

135

449

A10BH01

ATC

sitagliptin; oral

3.2

32.1

135

449

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.9

31.7

165

619

R03AC02

ATC

salbutamol; inhalant

1.9

31.5

911

6702

N61

ICD-10 Finland

Inflammatory disorders of breast

3.9

31.5

263

K05.31

ICD-10 Finland

Periodontitis pronounced

2.7

31.5

182

722

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

31.5

144

503

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

31.4

400

2237

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.9

31.2

932

6918

C07AB07

ATC

bisoprolol; oral

1.9

31.2

545

3403

E000001, ,

ATC

2.1

31.1

365

1978

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

31.1

503

3060

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

31.1

635

4174

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

30.8

405

2289

ZZA00

NOMESCO Finland

Split skin graft

6.2

30.8

N06AX16

ATC

venlafaxine; oral

2.2

30.6

304

1542

UJF32

NOMESCO Finland

Coloscopy

2.1

30.6

346

1847

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

30.3

1179

9519

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

30.3

324

1693

M54.5

ICD-10 Finland

Low back pain

1.9

30.3

619

4061

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

4.4

30.3

181

J01XC01

ATC

fusidic acid; systemic

6.5

30.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

29.9

649

4335

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

29.8

219

976

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

29.6

487

2971

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.0

29.5

386

2173

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

29.5

116

370

A10AE04

ATC

insulin glargine; parenteral

2.8

29.4

157

597

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

29.4

169

668

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.0

29.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

29.3

562

3604

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

4.2

29.2

199

E66

ICD-10 Finland

Obesity

3.0

29.1

141

508

L70.9

ICD-10 Finland

Acne, unspecified

9.6

28.9

A06AD11

ATC

lactulose; oral

2.7

28.9

175

710

P17

ICPC

Tobacco abuse

6.0

28.8

N03AX12

ATC

[U] gabapentin; oral

2.3

28.3

259

1268

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.9

28.0

134

WX002

NOMESCO Finland

Sedation and analgesia

2.2

27.8

274

1382

A10BK03

ATC

empagliflozin; oral

2.8

27.8

153

591

R96

ICPC

Asthma

2.7

27.6

162

646

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

27.2

638

4330

R95

ICPC

Chron obstructive pulmonary disease

6.3

27.2

SPAT1153

SPAT

Removal of sutures

1.9

27.1

419

2490

L03.3

ICD-10 Finland

Cellulitis of trunk

8.5

27.1

L17

ICPC

Foot/toe symptom/complaint

1.9

27.0

434

2612

ZY010

NOMESCO Finland

Hospital outpatient

2.9

26.9

138

513

J02AC01

ATC

fluconazole; systemic

1.8

26.9

693

4832

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.0

26.6

120

J01FA01

ATC

erythromycin; systemic

2.1

26.4

293

1546

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

26.3

428

2583

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

26.3

300

1598

P76

ICPC

Depressive disorder

2.5

26.0

171

721

L08.0

ICD-10 Finland

Pyoderma

9.1

26.0

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

6.4

25.8

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.3

25.8

207

956

L03

ICPC

Low back symptom/complaint

1.9

25.7

464

2894

EBA00

NOMESCO Finland

Extraction of tooth

1.8

25.6

606

4105

D07AB08

ATC

desonide; topical

2.4

25.3

199

911

Z3231

NOMESCO Finland

Registered nurse

1.9

25.3

403

2412

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.9

25.2

203

SPAT1310

SPAT

Counselling related to known health issue

1.8

25.2

499

3200

SPAT1254

SPAT

Administration of medicine

2.3

25.1

218

1041

SPAT1151

SPAT

Treatment of major wounds

10.2

24.8

H60.0

ICD-10 Finland

Abscess of external ear

10.2

24.8

J01DB05

ATC

cefadroxil; oral

3.2

24.7

101

330

L73.9

ICD-10 Finland

Follicular disorder, unspecified

24.8

24.4

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

5.1

24.3

102

L04AX03

ATC

methotrexate; systemic

2.5

24.3

170

738

N06AB10

ATC

escitalopram; oral

1.9

24.2

411

2506

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

24.2

503

3265

L71.8

ICD-10 Finland

Other rosacea

9.2

23.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

23.8

290

1579

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

23.8

796

5911

SPAT1283

SPAT

Restricted health certificate

1.9

23.6

418

2580

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

23.4

226

1126

N02AA05

ATC

oxycodone; systemic

2.3

23.2

190

883

S01

ICPC

Pain/tenderness of skin

3.4

23.2

269

L04AX01

ATC

azathioprine; systemic

3.3

23.1

280

L72.0

ICD-10 Finland

Epidermal cyst

7.8

23.0

WX290

NOMESCO Finland

Other blockage of nerve

1.7

22.9

867

6629

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

22.9

305

1711

N05CF01

ATC

zopiclone; oral

1.8

22.9

429

2691

A28

ICPC

Limited function/disability NOS

2.5

22.8

153

650

SPAT1211

SPAT

Application of soft bandage

2.6

22.8

146

607

SPAT1240

SPAT

Therapeutic discussion

2.1

22.6

242

1254

R05

ICPC

Cough

1.9

22.6

387

2359

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

22.4

202

978

D07AC13

ATC

mometasone; topical

1.8

22.3

441

2806

L28

ICPC

Limited function/disability (L)

2.2

22.2

197

947

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

22.1

382

2332

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

21.9

1188

9999

K02.1

ICD-10 Finland

Caries of dentine

1.7

21.9

1006

8068

A10BJ05

ATC

dulaglutide; parenteral

4.9

21.9

100

K50.8

ICD-10 Finland

Other Crohn disease

4.8

21.8

108

QBG99

NOMESCO Finland

Other operation for chronic ulcer or fistula of skin

116.7

21.6

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

21.5

117

448

L72.9

ICD-10 Finland

Follicular cyst of skin and subcutaneous tissue, unspecified

17.7

21.4

N06AB06

ATC

sertraline; oral

2.1

21.4

234

1221

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

21.3

166

754

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

20.6

223

1157

R06.0

ICD-10 Finland

Dyspnoea

1.9

20.6

346

2089

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.4

20.6

223

N06AB03

ATC

fluoxetine; oral

2.1

20.4

215

1104

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

7.3

20.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

20.3

213

1092

D11

ICPC

Diarrhoea

2.0

20.3

241

1294

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

20.2

400

2534

S06

ICPC

Rash localized

3.0

20.2

320

N06AX21

ATC

duloxetine; oral

2.1

20.2

213

1095

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.4

20.1

142

618

L71.9

ICD-10 Finland

Rosacea, unspecified

5.1

20.0

Z2446

NOMESCO Finland

Social worker

2.6

20.0

123

501

OAB50, ,

SPAT

3.0

20.0

311

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

19.9

104

390

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.8

19.9

101

373

G03HB01

ATC

cyproterone and estrogen; oral

2.0

19.9

226

1194

S21

ICPC

Skin texture symptom/complaint

2.1

19.8

207

1059

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

19.8

180

872

QDA10

NOMESCO Finland

Incision of skin of lower limb

15.5

19.8

H02AB07

ATC

prednisone; oral

2.2

19.7

192

957

N05AX08

ATC

risperidone; systemic

2.5

19.6

128

536

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.3

19.6

122

J01FA06

ATC

roxithromycin; oral

1.7

19.5

582

4121

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

19.4

168

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

4.4

19.3

115

R03BB04

ATC

tiotropium bromide; inhalant

2.6

19.3

118

479

P99

ICPC

Psychological disorders other

3.2

19.3

258

S99

ICPC

Skin disease other

4.9

19.3

A10BB12

ATC

glimepiride; oral

3.6

19.3

183

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.0

19.2

222

1180

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

5.0

19.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.3

19.0

157

731

A10AB05

ATC

insulin aspart; parenteral

2.5

19.0

120

495

N05BA01

ATC

diazepam; systemic, rectal

2.1

19.0

195

991

205

Kela drug reimbursment

Chronic hypertension

2.1

18.9

212

1113

B01AB05

ATC

enoxaparin; parenteral

1.8

18.9

393

2519

C07AA05

ATC

propranolol; systemic

1.8

18.8

365

2292

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.8

18.7

356

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

18.7

174

850

SPAT1058

SPAT

PEF monitoring instruction

2.5

18.5

117

483

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

18.4

323

1968

L01BA01

ATC

methotrexate; systemic

3.5

18.4

189

A03

ICPC

Fever

1.8

18.3

328

2011

N05AH03

ATC

olanzapine; systemic

2.4

18.2

137

612

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.2

18.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

18.2

208

1100

L88

ICD-10 Finland

Pyoderma gangrenosum

33.3

18.0

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.2

17.9

N03AX09

ATC

lamotrigine; oral

2.5

17.9

116

484

J01CF02

ATC

cloxacillin; systemic

4.7

17.8

WX402

NOMESCO Finland

General anaesthesia

1.8

17.8

329

2035

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.3

17.7

110

A02BC03

ATC

lansoprazole; oral

1.8

17.7

360

2288

SPAT1312

SPAT

General health counselling

1.7

17.7

485

3342

WZC30

NOMESCO Finland

Teaching

2.0

17.7

213

1147

9734

FHL

Excision and local plastic or associated free skin grafting

14.8

17.6

N07BB01

ATC

disulfiram; oral

2.8

17.6

322

C10AA01

ATC

simvastatin; oral

1.8

17.6

339

2120

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

2.0

17.6

200

1054

C08CA01

ATC

amlodipine; oral

1.7

17.6

364

2324

ZXC07

NOMESCO Finland

Carbon dioxide laser

96.2

17.6

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

17.6

289

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

17.5

143

662

68599

ICD-8 Finland

Pilonidal cyst

15.8

17.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

17.5

282

1672

L84

ICD-10 Finland

Corns and callosities

3.6

17.5

161

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.8

17.5

147

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

17.4

114

479

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.5

17.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

17.3

449

3046

N05CD07

ATC

temazepam; oral

2.4

17.3

119

511

UJF92

NOMESCO Finland

Capsular endoscopy

4.1

17.2

117

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

17.2

338

N05AH02

ATC

clozapine; systemic

3.7

17.0

150

R60.0

ICD-10 Finland

Localized oedema

2.3

16.9

142

665

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.1

16.9

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.3

16.8

200

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

16.8

171

865

R4190

NOMESCO Finland

Nutritional therapy

3.0

16.8

258

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

16.7

262

1537

R06AE07

ATC

cetirizine; oral

1.6

16.7

708

5402

N03AG01

ATC

valproic acid; systemic, rectal

2.5

16.7

111

469

C10AA05

ATC

atorvastatin; oral

1.7

16.7

396

2620

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

15.2

16.7

A02BC01

ATC

omeprazole; systemic

1.7

16.7

353

2264

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

16.6

145

690

N05AN01

ATC

lithium; oral

3.3

16.5

197

J20

ICD-10 Finland

Acute bronchitis

2.1

16.5

168

849

N05AA02

ATC

levomepromazine; systemic

2.9

16.4

272

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

23.3

16.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.0

16.4

121

R50.9

ICD-10 Finland

Fever, unspecified

1.9

16.4

232

1317

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.6

16.4

100

406

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

16.4

130

595

SFA10

NOMESCO Finland

One-surface restoration

1.6

16.1

883

7126

ZXE00

NOMESCO Finland

One hour or less

1.6

16.1

563

4100

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

16.0

344

2212

K04.08

ICD-10 Finland

Other specified pulpit

2.1

16.0

169

866

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

16.0

147

714

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

15.8

114

500

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.1

15.7

214

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.6

15.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

15.7

447

3093

9752

FHL

Surgical treatment of hyperhidrosis

+∞

15.6

M01AH05

ATC

etoricoxib; oral

1.6

15.5

919

7519

L02

ICPC

Back symptom/complaint

2.0

15.4

181

963

A10BJ02

ATC

liraglutide; parenteral

3.4

15.4

170

N05AX12

ATC

aripiprazole; systemic

2.5

15.3

102

431

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.8

15.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

15.3

100

419

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.3

15.3

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

15.3

148

734

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

15.3

192

1047

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

15.2

149

743

A10BD07

ATC

metformin and sitagliptin; systemic

3.3

15.1

177

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.0

15.0

SFA20

NOMESCO Finland

Two-surface restoration

1.6

15.0

943

7791

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

14.9

314

2003

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

14.9

458

3222

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

14.9

194

1071

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

14.9

335

2178

P29

ICPC

Psychological sympt/compl other

2.0

14.7

159

821

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.9

14.7

215

1231

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

14.6

112

504

70591

ICD-8 Finland

Diseases of sweat glands, Hidrosadenitis

+∞

14.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

14.6

316

2031

M25.5

ICD-10 Finland

Pain in joint

1.6

14.6

495

3560

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

14.6

236

1396

D07BC01

ATC

betamethasone and antiseptics; topical

2.0

14.5

169

896

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

14.5

169

897

E66.0

ICD-10 Finland

Obesity due to excess calories

6.7

14.5

N06AX05

ATC

trazodone; oral

3.3

14.4

167

160

Kela drug reimbursment

exenatide

4.2

14.4

A99

ICPC

Disease/condition unspecnature/site

2.2

14.4

131

633

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

14.4

128

613

RD210, ,

NOMESCO Finland

4.0

14.4

101

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

14.2

519

3790

L40.8

ICD-10 Finland

Other psoriasis

13.5

14.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

14.2

892

7323

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

14.2

420

2920

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

14.1

267

1651

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

14.1

120

565

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.1

14.1

201

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

13.9

197

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

13.9

532

3921

ZXA05

NOMESCO Finland

Left side

1.7

13.9

271

1690

N02BF01

ATC

gabapentin; oral

2.2

13.9

125

602

N06AX03

ATC

mianserin; oral

2.8

13.9

258

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.6

13.9

127

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

13.8

489

3540

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

13.8

420

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.7

13.8

288

1830

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.1

13.8

R06.5

ICD-10 Finland

Mouth breathing

2.1

13.8

138

693

K05.30

ICD-10 Finland

Periodontitis complex

1.9

13.6

187

1048

SGA01

NOMESCO Finland

Emergency treatment

1.7

13.6

304

1966

P03

ICPC

Feeling depressed

1.8

13.6

207

1200

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

13.6

244

H03AA01

ATC

levothyroxine sodium; systemic

1.7

13.5

321

2111

L30.3

ICD-10 Finland

Infective dermatitis

3.0

13.4

212

V03AA01, ,

ATC

5.1

13.4

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

5.6

13.4

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

13.4

162

871

SPAT1229

SPAT

Assessment of need for aid

2.6

13.4

298

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

13.3

121

585

ZXD05

NOMESCO Finland

Urgent procedure

1.6

13.3

451

3230

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

13.3

273

1727

R74

ICPC

Upper respiratory infection acute

1.5

13.2

589

4475

K08.3

ICD-10 Finland

Retained dental root

2.3

13.1

101

456

N02BF02

ATC

pregabalin; oral

2.4

13.1

405

H01

ICPC

Ear pain/earache

1.8

13.1

201

1167

B01AC04

ATC

clopidogrel; oral

2.1

13.1

126

623

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

13.1

130

651

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

13.0

145

757

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

13.0

175

975

ZXA10

NOMESCO Finland

Bilateral

1.8

13.0

214

1270

L30.4

ICD-10 Finland

Erythema intertrigo

5.3

13.0

-1, ,

NOMESCO Finland

1.5

12.9

548

4116

A10BX07

ATC

[U] liraglutide

5.1

12.9

J96.1

ICD-10 Finland

Chronic respiratory failure

5.7

12.9

A10BK01

ATC

dapagliflozin; oral

2.4

12.9

383

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

12.9

119

579

L05

ICPC

Flank/axilla symptom/complaint

2.4

12.9

402

J01CA04

ATC

amoxicillin; systemic

1.7

12.9

1267

11375

S19

ICPC

Skin injury other

2.9

12.8

212

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

12.8

136

697

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

12.8

318

2111

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.5

12.8

129

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

12.8

429

A07EC02

ATC

mesalazine; oral, rectal

2.4

12.8

410

QBB10, ,

SPAT

5.8

12.8

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.6

12.7

115

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.9

12.7

173

966

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

12.7

224

1355

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

12.7

126

630

A10BG03

ATC

pioglitazone; oral

4.3

12.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

12.7

143

750

UKC02

NOMESCO Finland

Cystoscopy

2.0

12.7

149

793

P72

ICPC

Schizophrenia

3.3

12.7

145

D05AX02

ATC

calcipotriol; topical

3.1

12.6

176

L68.0

ICD-10 Finland

Hirsutism

15.6

12.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

12.6

173

969

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

6.0

12.6

JHD20

NOMESCO Finland

Incision of fistula-in-ano

5.5

12.6

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.8

12.6

102

L15

ICPC

Knee symptom/complaint

1.6

12.6

311

2062

D10

ICPC

Vomiting

2.0

12.5

135

696

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

12.4

107

506

9731

FHL

Opening and channeling of the inflammatory site in the operating room or anesthesia

13.3

12.4

SPAT1255

SPAT

Intravenous administration of medicine

2.4

12.4

383

J01MA14

ATC

moxifloxacin; systemic

2.1

12.4

120

594

ZX120

NOMESCO Finland

Intravenous

2.1

12.4

123

615

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

12.3

1073

9297

R07

ICPC

Sneezing/nasal congestion

2.0

12.3

133

687

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

12.2

191

1114

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

12.2

128

654

L16

ICPC

Ankle symptom/complaint

1.8

12.2

182

1048

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

12.2

343

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

12.1

400

2838

P06

ICPC

Sleep disturbance

1.8

12.1

194

1142

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

12.1

208

1250

R51.80

ICD-10 Finland

Headache

1.7

12.0

271

1752

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.3

12.0

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.1

12.0

171

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.1

12.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

11.9

238

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

11.9

199

1184

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

11.9

181

1047

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

11.9

384

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.1

11.9

156

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

11.9

100

469

L86

ICPC

Back syndrome with radiating pain

2.3

11.9

404

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

11.8

144

775

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

11.8

283

1858

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

10.6

11.8

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

5.2

11.8

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

11.7

119

600

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

11.7

110

539

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

11.7

148

808

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

11.6

218

1341

A29

ICPC

General symptom/complaint other

1.9

11.6

155

860

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.1

11.6

153

F32

ICD-10 Finland

Depressive episode

2.1

11.6

108

527

N06AA09

ATC

amitriptyline; systemic

2.1

11.6

116

582

M03BX02

ATC

tizanidine; oral

1.5

11.6

930

7869

WX320

NOMESCO Finland

Spinalanesthesy

1.6

11.6

298

1991

L12

ICPC

Hand/finger symptom/complaint

1.7

11.6

238

1501

6850A

ICD-9 Finland

Pilonidal cyst, With abscess

23.1

11.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

11.5

254

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.8

11.5

208

L14

ICPC

Leg/thigh symptom/complaint

2.2

11.5

104

502

A02BA02

ATC

ranitidine; systemic

1.7

11.4

208

1268

K04.0

ICD-10 Finland

Pulpitis

1.8

11.4

185

1090

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

11.4

345

2393

S80.0

ICD-10 Finland

Contusion of knee

2.0

11.4

127

662

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.7

11.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

11.4

187

1108

K04.1

ICD-10 Finland

Necrosis of pulp

1.8

11.3

180

1055

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

11.3

110

546

SPE01

NOMESCO Finland

Mucosa-supported partial denture

4.3

11.3

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

11.3

400

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

5.0

11.2

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.6

11.2

101

D06

ICPC

Abdominal pain localized other

1.9

11.1

137

740

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

11.1

121

A02BC05

ATC

esomeprazole; systemic

1.5

11.1

525

4002

SPA47

NOMESCO Finland

Precision impression for denture

3.6

11.1

102

E000002, ,

ATC

1.8

11.0

177

1041

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.5

11.0

112

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

11.0

144

794

XQ845

NOMESCO Finland

Dermatoscopy

4.4

11.0

TUPKY, ,

NOMESCO Finland

4.4

11.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

11.0

123

643

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.9

11.0

D07AA02

ATC

hydrocortisone; topical

1.7

10.9

223

1403

N49.9

ICD-10 Finland

Inflammatory disorder of unspecified male genital organ

43.6

10.9

Z00.0

ICD-10 Finland

General medical examination

1.6

10.9

259

1695

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

3.2

10.9

138

H70

ICPC

Otitis externa

3.3

10.9

128

H60.3

ICD-10 Finland

Other infective otitis externa

3.2

10.8

139

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

10.8

349

2457

L11

ICPC

Wrist symptom/complaint

1.9

10.8

147

822

C09AA05

ATC

ramipril; oral

1.7

10.7

210

1307

J01DA06

ATC

[U] cefuroxime

1.7

10.7

208

1292

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.1

10.7

145

N01

ICPC

Headache

1.7

10.7

211

1316

A01

ICPC

Pain general/multiple sites

2.0

10.7

123

650

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.5

10.6

429

3163

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.0

10.6

M01AE02

ATC

naproxen; oral, rectal

1.4

10.6

852

7155

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

10.6

464

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.3

10.6

120

SFA30

NOMESCO Finland

Three-surface restoration

1.4

10.6

594

4671

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

10.6

451

KMAK, ,

NOMESCO Finland

1.4

10.6

820

6841

D01AC02

ATC

miconazole; topical

2.2

10.5

452

N75.1

ICD-10 Finland

Abscess of Bartholin gland

4.5

10.5

A10AE05

ATC

insulin detemir; parenteral

2.3

10.5

335

J46

ICD-10 Finland

Status asthmaticus

2.9

10.4

163

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

10.4

355

2523

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

10.4

147

L75.9

ICD-10 Finland

Apocrine sweat disorder, unspecified

+∞

10.4

X58

ICD-10 Finland

Exposure to other specified factors

1.7

10.4

216

1364

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

10.4

323

OAB72

NOMESCO Finland

Weight control and weight loss guidance

4.2

10.4

Z3226

NOMESCO Finland

Physiotherapist

1.7

10.4

230

1478

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

10.4

186

M79.1

ICD-10 Finland

Myalgia

1.7

10.4

233

1503

L21.0

ICD-10 Finland

Seborrhoea capitis

5.2

10.3

M01AB05

ATC

diclofenac; systemic, rectal

1.4

10.3

933

7988

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

10.3

396

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

10.3

257

D01

ICPC

Abdominal pain/cramps general

1.7

10.3

188

1148

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

10.2

125

674

SPAT1216

SPAT

Assessment of functional ability

1.9

10.2

143

806

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

10.2

464

L04AD01

ATC

ciclosporin; systemic

3.5

10.2

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.1

10.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

10.2

183

1112

N05AF03

ATC

chlorprothixene; systemic

2.8

10.1

177

J01FA10

ATC

azithromycin; systemic

1.4

10.1

906

7728

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

10.1

446

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

10.1

136

758

H13

ICPC

Plugged feeling ear

1.7

10.0

203

1273

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.3

10.0

114

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

4.8

10.0

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.5

10.0

242

D09AB01

ATC

zinc bandage without supplements; topical

4.1

10.0

T89

ICPC

Diabetes insulin dependent

2.3

10.0

323

R21

ICPC

Throat symptom/complaint

1.5

10.0

383

2790

M01AH01

ATC

celecoxib; oral

1.7

10.0

198

1236

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

9.9

150

865

AA1AD

NOMESCO Finland

CT of head and brain

1.6

9.9

262

1756

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

9.9

354

2538

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.5

9.9

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

9.9

147

844

XG466

NOMESCO Finland

Sleep oxymetry

3.1

9.9

136

SPAT1139

SPAT

Nutrition survey

3.0

9.8

147

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

4.4

9.8

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

9.8

417

R5110, ,

SPAT

2.4

9.8

300

A10AC01

ATC

insulin (human); parenteral

2.0

9.8

105

541

EB1VA, ,

NOMESCO Finland

1.7

9.7

191

1188

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

9.7

432

XQ802

NOMESCO Finland

Epicutan test

2.4

9.7

295

E000003, ,

ATC

2.3

9.7

314

SPAT1097

SPAT

Recording of ECG

1.8

9.7

146

841

L08

ICPC

Shoulder symptom/complaint

1.6

9.7

272

1849

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

9.7

277

1891

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

9.7

252

L30.0

ICD-10 Finland

Nummular dermatitis

2.7

9.7

199

E000006, ,

ATC

2.1

9.6

447

D02AX

ATC

Other emollients and protectives

2.6

9.6

205

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.3

9.6

N06AA06

ATC

trimipramine; systemic

3.1

9.6

133

S93

ICPC

Sebaceous cyst

8.4

9.6

N05AD01

ATC

haloperidol; systemic

3.1

9.5

128

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.0

9.5

144

R53

ICD-10 Finland

Malaise and fatigue

1.5

9.5

328

2334

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.9

9.5

161

M48.0

ICD-10 Finland

Spinal stenosis

2.0

9.5

102

526

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

9.5

324

SPAT1252

SPAT

Overall medication plan or its review

2.4

9.5

286

L50.9

ICD-10 Finland

Urticaria, unspecified

2.4

9.5

286

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.5

9.4

231

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

9.4

451

S85

ICPC

Pilonidal cyst/fistula

17.6

9.4

H3603, E103,

ICD-10 Finland

4.3

9.4

P74

ICPC

Anxiety disorder/anxiety state

2.0

9.4

486

SPAT1360

SPAT

Extensive global examination

2.2

9.4

391

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

12.4

9.4

IGY02, ,

SPAT

3.8

9.3

162

Kela drug reimbursment

liraglutide

4.4

9.3

R11

ICD-10 Finland

Nausea and vomiting

1.9

9.3

124

687

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

9.3

104

C09AA02

ATC

enalapril; systemic

1.8

9.3

157

936

ACC51

NOMESCO Finland

Release of median nerve

2.0

9.3

105

551

EBA30

NOMESCO Finland

Extraction of root of tooth

2.3

9.3

327

N05CF02

ATC

zolpidem; oral

1.6

9.3

243

1625

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

9.2

185

1156

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

9.2

115

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

9.2

145

847

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

9.2

105

R52.2

ICD-10 Finland

Other chronic pain

2.4

9.1

253

B02AA02

ATC

tranexamic acid; systemic

1.6

9.1

229

1515

QXB99, ,

SPAT

3.6

9.1

SPAT1104

SPAT

Monitoring of emergency patient

2.1

9.1

389

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

9.1

457

L60.0

ICD-10 Finland

Ingrowing nail

2.4

9.1

260

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.1

463

3554

K04.00

ICD-10 Finland

Hyperemia of pulp

2.1

9.1

451

G44.2

ICD-10 Finland

Tension-type headache

1.6

9.0

217

1421

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.7

9.0

177

S20

ICPC

Corn/callosity

3.7

9.0

SPAT1284

SPAT

Extensive health certificate

2.6

9.0

189

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

9.0

139

808

N05BA12

ATC

alprazolam; oral

1.8

9.0

137

793

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

9.0

105

558

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.8

9.0

155

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

9.0

134

771

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

9.0

231

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.5

8.9

219

S96

ICPC

Acne

3.4

8.9

R03BA01

ATC

beclometasone; inhalant

1.7

8.9

177

1104

H60

ICD-10 Finland

Otitis externa

2.0

8.9

454

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

8.9

200

1288

M01AH02

ATC

rofecoxib; oral

1.8

8.9

126

713

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

8.9

1389

13045

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.1

8.9

427

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

8.9

173

WX730

NOMESCO Finland

Conventional respirator

4.5

8.8

A05

ICPC

Feeling ill

1.9

8.8

111

604

H60.8

ICD-10 Finland

Other otitis externa

2.5

8.8

209

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.0

8.8

124

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

8.7

290

F34.1

ICD-10 Finland

Dysthymia

2.2

8.7

316

WX400

NOMESCO Finland

Inhalation anesthesy

2.2

8.7

310

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.6

8.7

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

8.7

522

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

8.7

119

667

J01FA09

ATC

clarithromycin; systemic

1.4

8.7

447

3433

ZX112

NOMESCO Finland

Subcutaneous

3.4

8.6

D10AX03

ATC

azelaic acid; topical

1.7

8.6

150

902

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

8.6

385

2878

A04

ICPC

Weakness/tiredness general

1.6

8.6

194

1250

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.6

8.6

D02AE01

ATC

carbamide; topical

2.0

8.6

453

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.9

8.6

131

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.6

8.6

B07.9

ICD-10 Finland

Verruca simplex

2.4

8.6

261

SPAT1210

SPAT

Application of cast or individual aid

2.4

8.5

255

ZXA00

NOMESCO Finland

Right side

1.5

8.5

268

1865

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.8

8.5

WX704

NOMESCO Finland

Intubation

1.9

8.5

104

561

56510

ICD-8 Finland

Anal fissure and fistula, Anal fistula

27.7

8.5

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.2

8.5

R52.9

ICD-10 Finland

Pain, unspecified

1.8

8.4

130

755

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

8.4

587

4743

UJH02

NOMESCO Finland

Anoscopy

2.4

8.4

232

P01

ICPC

Feeling anxious/nervous/tense

1.6

8.4

244

1669

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

8.4

395

C01DA14

ATC

isosorbide mononitrate; oral

2.1

8.4

368

N05AB03

ATC

perphenazine; systemic, rectal

2.4

8.4

251

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.7

8.4

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

8.4

437

H36.01

ICD-10 Finland

Diabetic maculopathy

4.0

8.3

A77

ICPC

Viral disease other/NOS

2.2

8.3

296

K08.80

ICD-10 Finland

Toothache NOS

1.7

8.3

152

926

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

8.2

446

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

8.2

344

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

14.6

8.2

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

8.2

318

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

8.2

241

SPAT1285

SPAT

Provision of consultation response

2.2

8.2

338

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

8.2

260

C10AA07

ATC

rosuvastatin; oral

1.5

8.2

322

2347

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

8.2

1052

9371

A07EA06

ATC

budesonide; oral, local oral

2.3

8.2

254

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

8.2

146

885

L04AA13

ATC

[U] leflunomide

2.9

8.2

124

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.1

8.2

108

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

8.1

603

4913

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.6

8.1

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

8.1

386

A10AE06

ATC

insulin degludec; parenteral

2.3

8.1

248

N05AB01

ATC

dixyrazine; systemic

4.6

8.1

R03AC03

ATC

terbutaline; inhalant

1.6

8.1

192

1251

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

8.1

113

636

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

8.1

119

681

-50

ICPC

Medication/prescr/renewal

2.4

8.1

224

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

8.0

423

3252

A08AB01

ATC

orlistat; oral

9.0

8.0

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

8.0

109

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

8.0

395

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.3

8.0

256

R4110

NOMESCO Finland

Physiotherapy

1.5

8.0

324

2372

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

8.0

107

595

J01MA01

ATC

ofloxacin; systemic

2.0

8.0

480

L04AA01

ATC

[U] ciclosporin

4.3

7.9

R5599

NOMESCO Finland

Other rehabilitation service

2.7

7.9

154

WZC00, ,

SPAT

1.7

7.9

141

853

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

7.9

439

M04AA01

ATC

allopurinol; systemic

1.9

7.9

496

N49.2

ICD-10 Finland

Inflammatory disorders of scrotum

13.1

7.9

RS221, ,

NOMESCO Finland

3.5

7.8

-, ,

ICD-10 Finland

3.3

7.8

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.3

7.8

266

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.7

7.7

R4180

NOMESCO Finland

Podiatric therapy

4.2

7.7

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

7.7

216

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.6

7.7

162

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

7.7

198

1316

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

7.7

229

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

7.7

296

2145

R03BA05

ATC

fluticasone; inhalant

1.5

7.7

249

1742

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

7.7

123

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

7.7

157

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

7.6

509

C10AA04

ATC

fluvastatin; oral

2.3

7.6

262

B01AA03

ATC

warfarin; systemic

1.8

7.6

119

694

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

7.6

121

710

T07

ICPC

Weight gain

3.0

7.6

113

R4120

NOMESCO Finland

Occupational therapy

2.0

7.6

446

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.9

7.6

124

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.6

7.6

164

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

8.9

7.5

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

7.5

170

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.7

7.5

141

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.8

7.5

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.1

7.5

103

H3601, E103,

ICD-10 Finland

4.3

7.5

Z2445

NOMESCO Finland

Psychologist

2.0

7.5

371

N18.8

ICD-10 Finland

Other chronic renal failure

3.9

7.4

R51

ICD-10 Finland

Headache

1.9

7.4

528

M01AX17

ATC

nimesulide; oral

1.5

7.4

233

1619

J01EA01

ATC

trimethoprim; systemic

1.4

7.4

325

2413

P15

ICPC

Chronic alcohol abuse

2.4

7.4

208

H60.1

ICD-10 Finland

Cellulitis of external ear

3.5

7.4

J45

ICD-10 Finland

Asthma

1.7

7.4

143

885

E0001A1, ,

ATC

2.6

7.4

154

S06.0

ICD-10 Finland

Concussion

1.7

7.4

142

878

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

7.4

503

4029

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

7.4

332

SPAT1281

SPAT

Other administrative function

1.8

7.4

108

618

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.0

7.4

K11.2

ICD-10 Finland

Sialoadenitis

2.4

7.3

209

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.7

7.3

149

B37.08

ICD-10 Finland

Other candidal stomatitis

8.4

7.3

N05BE01

ATC

buspirone; oral

2.4

7.3

197

ZXD20

NOMESCO Finland

Day surgery

1.6

7.3

164

1055

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

7.3

466

7062A

ICD-9 Finland

Diseases of sebaceous glands, Sebaceous cyst[CYSTA SEBACEA (ATHEROMA)]

+∞

7.3

L93.2

ICD-10 Finland

Other local lupus erythematosus

+∞

7.3

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

7.3

495

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

7.3

140

866

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

7.3

R78

ICPC

Acute bronchitis/bronchiolitis

3.0

7.3

105

R01AD08

ATC

fluticasone; nasal

1.4

7.2

420

3274

L03.8

ICD-10 Finland

Cellulitis of other sites

6.3

7.2

L73

ICD-10 Finland

Other follicular disorders

15.8

7.2

KFA40

NOMESCO Finland

Incision of scrotum

15.8

7.2

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.4

7.2

192

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

7.2

308

R81

ICPC

Pneumonia

2.5

7.2

180

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.5

7.2

180

N06AX26

ATC

vortioxetine; oral

1.7

7.2

127

767

M79.7

ICD-10 Finland

Fibromyalgia

2.2

7.2

262

N06AB05

ATC

paroxetine; oral

1.9

7.2

490

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.5

7.2

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

4.5

7.2

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

7.2

165

1068

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

7.2

121

722

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.2

7.2

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

7.1

187

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

7.1

457

3620

M01AC06

ATC

meloxicam; systemic, rectal

1.4

7.1

426

3336

OAB72, ,

SPAT

3.2

7.1

F01

ICPC

Eye pain

2.4

7.1

212

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.4

7.1

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

7.1

257

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.1

7.1

A10BJ01

ATC

exenatide; parenteral

4.1

7.1

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

7.1

194

A10AB01

ATC

insulin (human); parenteral

2.2

7.1

251

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

3.1

7.1

L70

ICD-10 Finland

Acne

2.5

7.0

164

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

7.0

126

764

Z00.8

ICD-10 Finland

Other general examinations

1.8

7.0

108

627

C09CA06

ATC

candesartan; oral

1.5

7.0

272

1971

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

7.0

217

1502

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

7.0

R31

ICD-10 Finland

Unspecified haematuria

1.9

7.0

444

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

7.0

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

7.0

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.2

7.0

XQ800

NOMESCO Finland

Prick test

1.7

7.0

119

712

H00.00

ICD-10 Finland

Hordeolum

2.0

7.0

388

-34

ICPC

Blood test

2.5

7.0

177

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

6.9

126

767

V03AE01

ATC

polystyrene sulfonate; oral

6.4

6.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

6.9

347

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.8

6.9

119

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.6

6.9

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

6.9

355

M10.9

ICD-10 Finland

Gout, unspecified

2.2

6.9

241

N06AG02

ATC

moclobemide; oral

2.2

6.9

254

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

6.9

131

C07AB02

ATC

metoprolol; systemic

1.6

6.9

157

1015

SPE90

NOMESCO Finland

Other partial denture

3.5

6.9

L70.2

ICD-10 Finland

Acne varioliformis

8.3

6.8

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

6.7

6.8

R03BA02

ATC

budesonide; inhalant

1.5

6.8

241

1716

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.7

6.8

126

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

6.8

147

2220

F05.9

ICD-10 Finland

Delirium, unspecified

4.3

6.8

F31

ICD-10 Finland

Bipolar affective disorder

3.1

6.8

A08

ICPC

Swelling

2.3

6.8

230

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

16.8

6.7

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

6.7

276

N05AL01

ATC

sulpiride; systemic

3.5

6.7

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

6.7

156

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

6.7

114

682

SPAT1234

SPAT

Support of social functional capacity

2.2

6.7

231

OSTO, ,

NOMESCO Finland

3.7

6.6

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

6.6

260

3486

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

6.6

147

944

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

6.6

326

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

6.6

106

624

C09CA01

ATC

losartan; oral

1.5

6.6

227

1607

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

6.6

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.4

6.6

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.3

6.6

201

K59.0

ICD-10 Finland

Constipation

2.1

6.6

286

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

6.6

286

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.5

6.5

158

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

10.1

6.5

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

6.5

208

SGC10

NOMESCO Finland

Pulp capping

1.6

6.5

159

1044

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.7

6.5

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.6

6.5

147

T83

ICPC

Overweight

2.5

6.5

153

A01AB09

ATC

miconazole; local oral

1.8

6.5

515

M54.3

ICD-10 Finland

Sciatica

1.9

6.5

406

TK800

NOMESCO Finland

Hemodialysis

3.2

6.5

S11

ICPC

Skin infection post-traumatic

3.5

6.4

H29

ICPC

Ear symptom/complaint other

1.7

6.4

126

783

R4110, ,

SPAT

1.8

6.4

538

S92.5

ICD-10 Finland

Fracture of other toe

2.2

6.4

222

L74.9

ICD-10 Finland

Eccrine sweat disorder, unspecified

70.1

6.4

OAB43, ,

SPAT

0.7

6.4

389

4858

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.9

6.4

436

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

6.4

365

K04.09

ICD-10 Finland

Pulpit UNS

1.8

6.4

466

N06AA12

ATC

doxepin; systemic

2.2

6.4

256

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

6.4

310

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

6.3

448

3592

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

6.3

283

K02.2

ICD-10 Finland

Caries of cementum

2.2

6.3

243

D06BX01

ATC

metronidazole; topical

1.7

6.3

128

802

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.9

6.3

ACC53

NOMESCO Finland

Release of ulnar nerve

3.1

6.3

A10BB01

ATC

glibenclamide; oral

3.6

6.3

Z01.2

ICD-10 Finland

Dental examination

1.3

6.3

661

5610

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.5

6.3

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

9.3

6.3

L72.2

ICD-10 Finland

Steatocystoma multiplex

18.1

6.3

SPAT1131

SPAT

Colonoscopy

2.7

6.2

126

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.0

6.2

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

6.2

138

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

6.2

144

X57

ICD-10 Finland

Unspecified privation

2.7

6.2

115

L20.0

ICD-10 Finland

Besnier prurigo

1.6

6.2

132

839

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.0

6.2

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.5

6.2

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.2

6.2

I20.00

ICD-10 Finland

Unstable angina

3.2

6.2

Z11

ICPC

Compliance/being ill problem

5.4

6.2

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.4

6.1

H3600, E113,

ICD-10 Finland

5.8

6.1

WX213

NOMESCO Finland

Lower leg blockade

5.8

6.1

ZYC03

NOMESCO Finland

Remote contact, text-based

5.8

6.1

R01AD09

ATC

mometasone; nasal

1.3

6.1

674

5750

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

6.1

356

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

6.1

328

L04AC05

ATC

ustekinumab; parenteral

7.7

6.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

6.1

428

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

6.1

240

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

6.1

308

L91.0

ICD-10 Finland

Hypertrophic scar

3.0

6.1

WX892

NOMESCO Finland

Monitored bed care

1.9

6.1

429

XCK00

NOMESCO Finland

Perimetry

2.1

6.1

281

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.1

6.1

288

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

6.1

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.6

6.1

134

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

10.1

6.0

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

6.0

101

602

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

6.0

289

R61

ICD-10 Finland

Hyperhidrosis

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

507

1299

5.37

192.81

2.3

1.5

—

(3042936) Bacteria identified in Isolate by Culture

512

1458

4.80

168.70

2.8

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

999

5671

3.24

102.52

9.3

6.2

—

(3006315) Basophils [#/volume] in Blood

1028

6011

3.22

98.60

8.6

5.8

0.05

0.04

e9/l

9.19

952

5290

(3013115) Eosinophils [#/volume] in Blood

1051

6226

3.25

98.49

8.8

6.1

0.20

0.18

e9/l

4.46

979

5566

(3001604) Monocytes [#/volume] in Blood

1026

5999

3.21

98.29

8.6

5.8

0.62

0.55

e9/l

19.11

945

5289

(3019198) Lymphocytes [#/volume] in Blood

1037

6235

3.11

91.84

8.7

5.8

2.24

1.97

e9/l

12.12

972

5627

(3022096) Basophils/100 leukocytes in Blood

929

5420

2.85

83.97

8.5

5.9

0.64

0.67

1.29

901

5089

(3019069) Monocytes/100 leukocytes in Blood

958

5682

2.87

83.83

8.8

6.1

7.74

8.13

5.23

932

5366

(3006504) Eosinophils/100 leukocytes in Blood

952

5644

2.85

83.08

8.5

5.8

2.62

2.78

1.96

921

5316

(3013650) Neutrophils [#/volume] in Blood by Automated count

1080

6869

3.00

81.97

12.2

8.7

4.81

3.99

e9/l

25.86

1000

6065

(3002030) Lymphocytes/100 leukocytes in Blood

969

5917

2.77

77.72

8.6

5.8

28.04

29.25

3.63

937

5604

(3018010) Neutrophils/100 leukocytes in Blood

961

5853

2.76

77.31

8.2

5.6

58.47

56.51

7.09

933

5536

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1238

8680

3.35

75.32

9.5

6.8

81.58

74.22

u/l

4.64

1200

8211

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

921

5601

2.65

72.45

5.4

5.6

9.48

10.52

umol/l

1.54

875

5300

(3024561) Albumin [Mass/volume] in Serum or Plasma

752

4217

2.56

69.09

6.2

4.6

35.36

36.74

g/l

9.22

717

3966

(3013826) Glucose [Moles/volume] in Serum or Plasma

968

6359

2.45

59.51

5.5

4.4

6.86

6.43

mmol/l

6.26

904

5818

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

627

3426

2.42

58.37

3.2

2.5

51.23

57.35

u/l

2.19

580

3192

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

160

405

4.30

57.60

1.8

1.5

0.06

0.20

iu/ml

0.48

(3023368) Bacteria identified in Blood by Culture

484

2394

2.50

55.63

4.7

4.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1186

8806

2.60

51.82

5.6

3.6

14.93

9.70

mm/h

23.66

1129

8230

(3022217) INR in Platelet poor plasma by Coagulation assay

702

4188

2.26

51.52

10.0

8.8

1.13

inr

0.02

254

1378

(3023520) Reticulocytes [#/volume] in Blood

192

607

3.48

50.08

3.6

2.7

82.85

72.24

e9/l

3.39

169

444

(3020682) Albumin/Creatinine [Ratio] in Urine

502

2632

2.36

49.73

4.6

3.9

14.72

9.14

mg/mmol

0.86

345

1720

(3012516) Albumin [Mass/volume] in Urine

484

2511

2.36

49.00

3.8

3.4

512.45

305.28

mg/l

0.42

347

1658

(3037522) Nuclear Ab [Titer] in Serum

378

1760

2.53

48.56

1.4

1.3

481.45

573.68

titre

0.50

351

(3017181) Myelocytes/100 leukocytes in Blood

246

925

2.98

47.93

5.5

4.3

0.50

1.00

3.41

113

301

(3002179) Metamyelocytes/100 leukocytes in Blood

233

851

3.05

47.79

5.4

4.1

0.37

0.61

1.23

105

257

(3009508) Creatinine [Moles/volume] in Urine

552

3070

2.26

47.05

3.9

3.3

7.79

8.21

mmol/l

1.16

480

2691

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

751

4810

2.11

43.82

8.2

6.1

1.21

mmol/l

0.50

657

4097

(3021440) Promyelocytes/100 leukocytes in Blood

231

881

2.91

43.65

5.6

4.4

0.03

0.13

2.93

255

(3027945) Reticulocytes/100 erythrocytes in Blood

230

877

2.91

43.47

3.5

2.7

1.93

1.72

2.70

219

789

(3048689) Calprotectin [Mass/mass] in Stool

365

1779

2.39

41.69

3.2

2.4

132.18

110.58

ug/g

0.44

296

1424

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

731

4761

2.04

39.40

2.9

2.2

68.77

74.04

nmol/l

6.24

679

4426

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

665

4188

2.05

39.34

3.4

3.2

32.40

29.93

u/l

0.30

636

3983

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

629

3883

2.06

39.30

2.0

1.7

96.44

97.26

pmol/l

0.17

370

2131

(3025159) Blasts/100 leukocytes in Blood

216

842

2.83

38.98

5.9

4.5

0.00

0.50

0.73

214

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1302

10649

2.60

37.27

7.1

4.4

40.93

38.20

mmol/mol

14.56

1234

10103

(3017143) Hepatitis C virus Ab [Presence] in Serum

373

1965

2.19

34.65

1.7

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

660

4283

1.96

34.58

6.9

5.5

1.21

mmol/l

0.49

628

3952

(3019550) Sodium [Moles/volume] in Serum or Plasma

1418

12258

3.50

33.90

19.1

11.0

139.17

139.59

mmol/l

9.26

1395

11923

(3022948) Iron [Moles/volume] in Serum or Plasma

311

1538

2.29

33.61

3.0

2.3

12.13

14.69

umol/l

7.50

290

1438

(3023103) Potassium [Moles/volume] in Serum or Plasma

1420

12302

3.51

33.48

19.3

11.0

3.97

3.92

mmol/l

8.77

1398

11944

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

174

666

2.82

32.26

1.8

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

455

2658

2.02

31.71

2.9

2.0

2.98

2.72

mg/l

1.41

408

2299

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

205

883

2.53

29.97

2.4

2.3

0.22

0.23

g/l

0.41

198

831

(3019309) Folate [Moles/volume] in Red Blood Cells

295

1491

2.22

29.94

1.8

1.7

1170.48

1189.96

nmol/l

0.13

230

1179

(3021589) Normoblasts [#/volume] in Blood

767

5404

1.85

29.74

13.3

8.2

0.00

e9/l

0.44

672

4445

(3009343) pH of Capillary blood

148

542

2.92

29.71

3.1

7.43

7.41

1.76

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

149

548

2.91

29.68

3.1

5.11

5.14

kpa

0.20

144

525

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

287

1466

2.18

28.23

1.9

1.8

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

218

3.97

28.17

3.6

3.8

4.71

4.05

e9/l

1.96

218

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

224

3.91

27.92

3.8

4.2

58.42

56.60

0.79

224

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

141

522

2.88

27.71

3.2

3.1

1.77

1.54

mmol/l

0.25

111

369

(3037467) Urinalysis macro (dipstick) panel - Urine

1058

8342

1.89

27.60

5.0

3.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

363

2048

2.02

27.32

1.9

1.6

402.75

43969299.30

pmol/l

2.61

307

1799

(3021960) Folate [Moles/volume] in Serum or Plasma

371

2116

2.00

27.04

1.7

1.4

19.20

20.50

nmol/l

0.75

339

1871

(3000850) Epithelial cells [#/volume] in Urine

371

2132

1.98

26.38

3.3

2.3

6.74

7.50

e6/l

0.51

351

1918

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1421

12604

3.10

26.35

20.4

10.7

20.03

20.59

mg/l

0.29

1290

9706

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

465

2883

1.88

26.33

2.0

186.51

185.63

u/l

0.01

443

2740

(3026008) Bacteria identified in Urine by Culture

485

3063

1.86

25.82

2.8

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

269

1390

2.14

25.49

3.1

2.2

2.41

2.42

g/l

0.11

251

1291

(3018418) pH of Serum or Plasma

453

2843

1.85

24.34

4.5

3.7

7.39

7.40

0.57

557

(3003458) Phosphate [Moles/volume] in Serum or Plasma

234

1166

2.19

24.24

8.1

6.0

1.09

1.04

mmol/l

1.64

221

1104

(3031040) Bacteria [#/volume] in Urine by Automated count

994

7835

1.78

24.21

5.0

3.7

595.92

927.92

e6/l

0.21

(3002582) Erythrocytes [#/volume] in Urine

486

3127

1.82

24.02

3.7

2.8

31.60

89.76

e6/l

1.19

390

2362

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

7.07

23.81

3.3

2.7

185.58

90.75

au/ml

—

(3000494) Fungus identified in Specimen by Culture

256

1330

2.11

23.80

1.6

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1190

9931

1.93

23.80

5.1

4.0

14.58

14.42

pmol/l

1.50

1115

9255

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1334

11602

2.27

23.73

5.0

3.6

6.20

5.73

mmol/l

21.21

1241

10850

(3026493) Urate [Moles/volume] in Serum or Plasma

439

2753

1.84

23.51

2.5

2.4

1650.13

4001.08

umol/l

1.32

396

2502

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

6.75

23.46

2.1

2.4

8.78

10.20

mg/l

0.58

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

246

1266

2.13

23.42

3.3

2.3

20.40

24.83

4.89

208

1094

(3018095) Leukocytes [#/volume] in Urine

570

3871

1.76

23.28

4.1

3.2

63.41

71.12

e6/l

0.10

418

2575

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1332

11603

2.24

23.18

6.0

4.6

1.79

1.98

mu/l

0.61

1253

10954

(3030467) Casts [#/volume] in Urine by Automated count

448

2844

1.82

22.96

3.5

2.7

0.43

0.37

e6/l

0.21

363

2119

(3012095) Magnesium [Moles/volume] in Serum or Plasma

282

1540

2.02

22.84

3.1

3.6

0.79

0.82

mmol/l

4.51

266

1472

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1113

9142

1.82

22.78

3.9

2.9

54.25

39.98

u/l

6.15

1063

8745

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

537

3603

1.76

22.77

3.3

2.8

42.72

29.07

ng/l

0.82

277

1892

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

489

3205

1.78

22.41

1.4

1.3

1.58

1.46

u/ml

0.07

151

915

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

199

958

2.24

22.35

2.3

4.3

208.58

239.85

u/l

3.24

182

915

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1463

13374

3.84

22.19

15.8

8.5

28.80

26.59

u/l

2.27

1444

13007

(36304419) Bacteria [Presence] in Urine

444

2848

1.79

21.79

3.5

2.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

128

511

2.64

21.69

1.3

1.2

0.30

1.47

u/ml

1.12

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

106

388

2.86

21.21

1.7

2.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

329

1938

1.89

21.19

2.3

1.8

1.55

1.40

2.28

292

1751

(3035350) Ketones [Presence] in Urine by Test strip

795

6021

1.68

21.05

4.1

3.1

0.00

estimate

1.08

207

1252

(3021879) Hepatitis B virus core Ab [Presence] in Serum

242

1286

2.05

21.01

1.4

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

7.17

20.82

2.0

2.1

161.00

201.83

au/ml

—

(3009261) Glucose [Presence] in Urine by Test strip

798

6065

1.67

20.71

4.1

3.1

0.03

0.01

estimate

0.62

186

1165

(40768443) Skin Pathology biopsy report

105

389

2.83

20.54

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

450

2947

1.75

20.31

2.1

1.6

1.70

1.39

mmol/l

6.79

400

2555

(3003396) Base excess in Arterial blood by calculation

185

899

2.21

20.23

8.0

9.2

1.18

1.03

mmol/l

0.21

149

718

(3015377) Calcium [Moles/volume] in Serum or Plasma

504

3413

1.71

20.14

3.0

3.1

2.36

2.35

mmol/l

1.69

455

3112

(3021601) Nitrite [Presence] in Urine by Test strip

789

6014

1.65

19.96

5.2

4.2

0.00

estimate

0.50

204

1216

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1367

12194

2.25

19.77

5.3

3.7

4.59

4.78

mmol/l

10.44

1293

11631

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

325

1955

1.84

19.42

2.4

2.8

1146.20

753.83

ng/l

0.75

262

1590

(3044889) 12 lead EKG panel

965

7775

1.67

19.35

3.6

3.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

183

904

2.17

19.17

8.0

9.1

11.19

12.88

kpa

6.91

177

870

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

183

904

2.17

19.17

8.1

9.1

5.25

5.11

kpa

1.12

177

867

(3028026) IgM [Mass/volume] in Serum or Plasma

151

695

2.30

18.78

1.5

1.8

1.15

1.34

g/l

1.15

134

650

(3022145) Colonoscopy Study observation

225

1212

2.01

18.69

1.4

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1319

11673

2.01

18.46

4.7

3.3

1.60

1.27

mmol/l

33.43

1245

11062

(3021901) Oxygen saturation in Capillary blood

142

3.91

18.32

2.6

2.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

200

1044

2.06

18.10

3.1

2.2

4826.18

5881.21

u/l

0.19

452

(3019060) Gas panel - Arterial blood

117

490

2.50

17.94

4.8

7.2

—

(3037121) Protein [Mass/volume] in Urine

354

2.77

17.83

3.8

3.7

0.32

0.27

g/l

0.21

151

(3006184) Hemoglobin [Mass/volume] in Capillary blood

203

3.35

17.77

2.5

2.2

132.89

133.20

g/l

0.03

154

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

193

1001

2.06

17.76

3.6

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

464

3176

1.66

17.28

4.8

3.4

0.00

0.01

estimate

1.28

195

1191

(3005719) IgG [Mass/volume] in Serum or Plasma

177

902

2.09

17.05

2.7

11.01

10.40

g/l

1.20

166

830

(3036481) Cortisol [Moles/volume] in Serum or Plasma

211

1146

1.98

17.04

2.1

2.0

367.31

375.71

nmol/l

0.25

194

1068

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

743

5726

1.58

16.88

2.7

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1365

12311

2.11

16.87

5.2

3.9

2.78

2.88

mmol/l

4.33

1281

11670

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

187

977

2.04

16.83

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

410

2740

1.68

16.63

1.5

1.4

2.58

2.24

g/l

2.81

277

1791

(40758558) Short blood count panel - Blood

429

2912

1.66

16.35

7.8

6.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1348

12152

2.00

15.92

4.7

3.6

1.29

1.47

mmol/l

55.41

1267

11544

(3026782) Osmolality of Urine

320

2022

1.74

15.86

3.2

2.5

514.51

543.47

mosm/kgh2o

1.35

289

1759

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

413

2798

1.65

15.76

1.8

1.7

0.76

0.92

mg/l

0.94

313

2080

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

224

1275

1.89

15.68

2.1

2.7

8.91

7.02

umol/l

0.39

172

1091

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1305

11681

1.85

15.16

16.5

9.1

94.05

91.27

ml/min/173m2

4.25

1136

9505

(3015736) pH of Urine

649

4941

1.55

14.94

3.9

2.9

5.78

5.89

0.40

526

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

184

1000

1.96

14.76

1.7

—

(40768797) Stomach Pathology biopsy report

248

1493

1.79

14.42

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

319

2.63

14.11

1.2

1.3

86.25

102.69

titre

—

(40761511) CBC panel - Blood by Automated count

1444

13470

2.58

14.03

18.2

9.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

141

3.48

13.92

1.6

1.3

—

(3002256) Pathology report gross observation

238

1432

1.79

13.83

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

628

4812

1.52

13.67

2.1

1.9

—

(3022313) Gas panel - Capillary blood

398

2.42

13.62

3.2

3.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

341

2276

1.64

13.52

1.3

24.64

27.01

iu/ml

0.13

753

(3011397) Hemoglobin [Presence] in Urine by Test strip

381

2614

1.61

13.52

4.2

3.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

282

1793

1.70

13.46

3.9

3.0

312.30

532.44

ng/l

0.58

163

1097

(3033658) Prothrombin time (PT) actual/Normal

396

2749

1.60

13.35

4.3

3.5

96.27

95.75

0.17

381

2669

(3001122) Ferritin [Mass/volume] in Serum or Plasma

769

6169

1.50

13.31

3.6

2.8

108.60

88.37

ug/l

2.24

724

5816

(40767503) Oxygen content in Capillary blood by calculation

171

3.18

13.26

3.0

2.2

16.62

16.97

0.21

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

618

4752

1.51

13.06

4.3

3.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

433

2.33

12.93

10.7

12.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

115

554

2.16

12.77

2.8

2.7

143.46

121.60

ng/l

0.24

101

487

(46235355) HIV 1 and 2 tests - Meaningful Use set

528

3947

1.52

12.67

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

445

3208

1.55

12.61

1.8

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

104

485

2.23

12.51

2.0

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

144

765

1.98

12.29

4.9

3.3

1.22

1.23

mmol/l

0.83

126

662

(3020891) Body temperature

307

2.52

12.10

3.6

4.8

—

(3047181) Lactate [Moles/volume] in Blood

290

2.56

12.01

6.1

9.1

1.28

1.20

mmol/l

0.50

250

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

279

2.58

11.93

2.7

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

124

633

2.04

11.83

4.7

4.0

107.10

76.93

ng/l

1.50

114

573

(3025941) Bacteria identified in Stool by Culture

146

794

1.93

11.63

1.3

1.2

—

(3013512) EKG study

372

2617

1.56

11.62

3.6

2.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

466

3450

1.51

11.47

1.8

1.6

—

(3012501) Base excess in Blood by calculation

205

2.80

11.27

5.4

3.2

2.28

2.23

mmol/l

0.05

127

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

2.36

11.19

2.2

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

257

1673

1.65

11.06

2.7

2.4

1.41

1.32

e6/l

0.09

144

899

(1616796) Gas panel - Central venous blood

202

2.79

11.01

5.8

2.8

—

(40761535) Cells panel - Urine sediment

142

789

1.88

10.60

4.3

3.1

—

(4200892) Spirometry reversibility

132

726

1.90

10.16

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

479

2.10

10.13

1.7

1.6

—

(3000991) Gas panel - Venous blood

129

707

1.90

10.04

9.4

8.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

566

2.00

9.93

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

311

2170

1.55

9.90

1.4

1.3

9.88

9.96

u/ml

0.01

124

936

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

248

1648

1.60

9.74

2.5

2.6

2.45

2.42

mmol/l

3.04

218

1459

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

371

2703

1.49

9.60

2.3

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.48

9.56

1.7

3.7

121.67

154.79

umol/l

—

(3052851) Hemolysis interference index of Serum or Plasma

285

2.38

9.54

2.7

2.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

395

2.17

9.54

2.2

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

474

3627

1.45

9.53

2.4

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

251

2.45

9.30

2.6

2.9

—

(3011288) Drugs identified in Urine by Screen method

117

638

1.90

9.25

3.2

2.9

—

(3019150) Specific gravity of Urine by Refractometry

355

2589

1.48

9.08

4.7

3.3

1.02

kg/l

0.48

353

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

3.25

8.79

2.3

3.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

224

1488

1.59

8.77

2.0

2.1

30.19

29.47

0.72

219

1445

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

182

1150

1.66

8.71

6.9

5.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

153

2.79

8.59

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

413

2.07

8.52

3.1

2.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

284

2.27

8.29

1.2

29.34

33.79

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

124

714

1.80

8.27

2.5

2.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

162

2.70

8.27

1.8

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

105

575

1.89

8.21

1.7

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

232

2.38

7.94

1.4

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

226

2.39

7.92

1.1

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

214

2.43

7.89

1.2

1.7

0.37

0.77

g/l

3.23

160

(3016879) Cocaine [Presence] in Urine

139

839

1.72

7.88

2.6

2.2

—

(3019225) pH of Specimen

145

893

1.69

7.64

6.0

3.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

314

2.15

7.64

1.6

1.3

—

(36660697) Celiac disease serology panel - Serum

169

1088

1.62

7.50

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

166

1065

1.63

7.47

3.2

2.4

38.47

86.50

u/l

0.54

148

911

(3000012) Reticulocyte production index

3.16

7.43

1.6

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

319

2.12

7.35

1.4

2.2

1.72

1.41

g/l

2.19

281

(40761536) Microorganisms panel - Urine sediment

171

1110

1.61

7.34

4.9

3.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

307

2.13

7.27

1.9

2.1

1.50

2.02

ug/l

0.21

280

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

110

636

1.79

7.25

2.2

2.1

6.24

7.91

ug/l

0.46

577

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

127

2.80

7.25

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1487

14405

2.88

7.24

30.3

15.7

40.92

40.89

0.03

1404

13720

(3002032) Base excess in Venous blood by calculation

127

766

1.72

7.23

5.3

3.6

2.21

1.86

mmol/l

0.45

105

645

(3000570) Elastase.pancreatic [Mass/mass] in Stool

303

2.13

7.11

1.3

1.5

308.79

313.88

ug/g

0.06

167

(3025468) Yersinia sp identified in Specimen by Organism specific culture

129

2.75

7.05

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

213

2.34

7.05

2.6

2.4

186.72

88.92

ug/min

0.71

134

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

292

2.13

6.98

1.3

1.4

23.26

21.75

u/l

0.17

247

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

221

2.31

6.93

1.0

1.1

109.56

2244.94

iu/ml

0.49

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

131

2.71

6.86

1.4

—

(4062490) Immunoglobulin typing, IgG

137

2.67

6.83

1.3

1.4

—

(3007461) Platelets [#/volume] in Blood

1486

14414

2.73

6.77

30.3

15.7

276.96

259.49

e9/l

19.52

1473

14102

(3024731) MCV [Entitic volume]

1487

14429

2.78

6.75

30.1

15.6

90.85

90.14

7.05

1480

14273

(3035941) MCH [Entitic mass]

1487

14432

2.77

6.69

30.0

15.6

30.15

30.12

0.25

1480

14274

(3010813) Leukocytes [#/volume] in Blood

1487

14434

2.76

6.65

30.3

15.7

7.89

6.72

e9/l

52.46

1470

14096

(3026361) Erythrocytes [#/volume] in Blood

1487

14434

2.76

6.65

30.2

15.6

4.56

4.55

e12/l

0.08

1474

14100

(3009214) Lutropin [Units/volume] in Serum or Plasma

533

1.81

6.63

1.3

1.4

11.79

9.37

u/l

1.00

450

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

142

903

1.63

6.63

2.7

3.3

4.41

4.58

pmol/l

1.15

120

818

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

100

2.94

6.60

2.0

34.21

32.47

1.32

100

(3042631) Mycobacterium sp identified in Specimen

2.98

6.55

2.1

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

224

1583

1.49

6.55

2.8

2.6

5.48

3.35

e6/l

1.35

111

819

(3003327) Ova and parasites identified in Stool by Light microscopy

477

1.85

6.51

1.8

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

1487

14442

2.72

6.49

30.4

15.7

136.49

136.53

g/l

0.03

1480

14283

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

130

2.65

6.41

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

130

2.65

6.41

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

229

2.22

6.40

1.2

—

(3028300) Cannabinoids [Presence] in Urine

141

904

1.62

6.37

2.6

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

223

2.24

6.37

2.8

4.2

0.32

0.37

u/ml

0.50

109

(3024522) Salmonella sp identified in Specimen by Organism specific culture

131

2.63

6.32

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

176

1191

1.54

6.31

4.2

3.5

29.96

31.36

0.98

143

880

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

238

2.18

6.24

1.3

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

193

2.32

6.23

1.8

3.2

1.33

1.75

ratio

—

(3027944) Amphetamines [Presence] in Urine

138

885

1.62

6.23

2.6

2.1

—

(3027008) Opiates [Presence] in Urine

140

901

1.61

6.23

2.6

2.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

140

904

1.60

6.15

1.4

1.3

262.97

221.12

u/ml

0.26

131

842

(3028192) IgG subclass 2 [Mass/volume] in Serum

134

2.57

6.06

1.3

1.4

3.55

2.82

g/l

1.14

(3027135) IgG subclass 1 [Mass/volume] in Serum

134

2.57

6.06

1.3

1.4

6.34

g/l

0.00

(3024139) IgG subclass 3 [Mass/volume] in Serum

134

2.57

6.06

1.3

1.4

0.42

0.36

g/l

0.54

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

2.17

6.03

5.2

6.3

322.30

343.17

iu/ml

—

(3000764) Benzodiazepines [Presence] in Urine

138

893

1.60

6.01

2.6

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

442

3562

1.34

5.99

3.5

2.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

197

2.27

5.96

1.9

3.3

51.16

70.45

mg/l

0.25

155

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

197

2.27

5.96

1.9

3.3

36.84

30.87

mg/l

0.41

154

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

2.08

5.94

1.5

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

1218

11321

1.39

5.92

23.7

12.8

14.78

14.27

2.84

1206

11118

(3008898) HLA-B27 [Presence]

104

629

1.70

5.90

1.1

—

(3036180) Methadone [Presence] in Urine

2.89

5.79

2.4

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

357

1.92

5.76

4.7

3.4

25.12

25.13

mmol/l

0.01

345

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

341

2662

1.36

5.65

2.2

2.1

—

(3023419) Bacteria identified in Sputum by Culture

128

2.53

5.55

1.8

2.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.02

5.54

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

348

1.91

5.53

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

156

2.34

5.28

1.8

3.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

588

1.68

5.22

1.9

1.5

—

(21494755) Public health laboratory ask at order entry panel

135

1961

0.66

5.11

1.2

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.87

5.09

1.3

2.6

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

13.39

5.08

2.4

1.8

4.22

2.83

mg/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.69

4.93

1.7

1.2

102.48

82.74

nmol/24h

0.29

(3012441) Differential panel - Pleural fluid

3.36

4.89

1.2

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

126

840

1.55

4.86

2.2

2.1

9.64

12.67

nmol/l

3.75

113

775

(3021788) Differential panel - Synovial fluid

164

2.22

4.74

1.6

1.7

—

(3017732) Neutrophils [#/volume] in Blood

130

879

1.52

4.70

2.3

2.7

5.21

5.61

e9/l

0.22

109

780

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

218

2.05

4.70

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.73

4.69

3.0

39973.91

40064.09

ug/l

0.01

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

103

2.55

4.64

2.9

1.8

27.36

13.52

mg/l

1.02

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

452

1.72

4.63

2.1

2.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

140

2.31

4.63

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.78

4.62

1.4

1.5

34.87

35.17

0.01

(3043238) Trisomy 21 risk [Likelihood] in Fetus

672

0.46

4.61

1.6

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

656

0.46

4.57

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

118

788

1.54

4.53

1.1

1.2

—

(1002224) Polysomnography panel

102

659

1.59

4.52

1.1

—

(3005033) Fetal Nuchal fold Thickness US

653

0.46

4.51

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

111

2.46

4.48

1.3

1.7

42.23

56.03

0.71

(3000475) Leukocytes [#/volume] in Synovial fluid

216

2.02

4.44

1.6

1.7

5985.00

12148.55

e6/l

1.15

166

(3000492) Spirometry study

184

1349

1.41

4.41

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1151

0.60

4.37

1.2

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

144

1013

1.47

4.31

1.3

24.60

24.46

iu/l

0.02

122

860

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.55

4.31

1.5

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

110

733

1.54

4.27

3.1

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

172

2.12

4.25

1.3

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

794

0.53

4.24

1.3

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

132

917

1.48

4.22

2.3

25.08

21.23

au/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

270

1.88

4.21

1.7

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.44

4.19

1.3

1.1

—

40.00

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.44

4.19

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

790

0.53

4.17

1.3

1.4

—

(40768441) Liver Pathology biopsy report

2.73

4.09

1.1

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

861

0.55

4.09

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

795

0.54

4.04

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

794

0.54

4.03

1.3

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.03

4.00

3.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

143

2.19

4.00

1.3

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

321

1.77

3.92

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

106

2.38

3.91

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

116

1646

0.68

3.89

1.4

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

359

2962

1.28

3.87

2.3

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

116

800

1.49

3.86

2.6

4.3

8.87

21.92

ug/l

0.78

614

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

258

1.85

3.79

1.6

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

108

2.34

3.77

1.5

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

231

1.89

3.71

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

128

2.21

3.71

1.7

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

101

683

1.51

3.70

1.4

1.3

221.03

227.84

miu/ml

0.07

347

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

109

2.32

3.69

1.5

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

2.81

3.69

1.5

146.94

145.92

nmol/l

0.02

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

224

1746

1.33

3.68

1.7

1.9

—

(3017704) Immunofixation for Urine

3.13

3.65

1.1

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

516

1.58

3.62

1.7

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

4.02

3.59

6.8

8.7

28.27

25.08

mmol/l

1.78

(3044941) Cell count panel - Synovial fluid

150

2.09

3.58

1.7

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.37

3.58

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.81

3.56

1.1

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

487

1.59

3.54

3.6

3.1

129.50

131.74

g/l

0.36

479

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

250

1.82

3.52

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

236

1.85

3.50

4.0

2.5

1.02

0.86

nmol/l

0.74

203

(44813793) Dust mix specific IgE antibody measurement

2.39

3.49

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.63

3.47

1.2

1.1

1320.69

1467.23

miu/ml

0.26

(4146454) Self-monitoring of blood glucose

2.55

3.47

2.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.90

3.47

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

522

1.56

3.46

1.6

2.1

35.98

39.53

u/l

0.95

481

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.57

3.43

1.0

1.6

9.12

11.28

g/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

532

1.55

3.41

1.5

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

254

1.80

3.36

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

115

816

1.44

3.34

1.6

299.72

298.34

mu/l

0.02

105

733

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.73

3.32

1.5

3.3

658.13

1164.49

u/ml

0.62

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

256

1.78

3.28

1.3

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.04

3.25

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

103

2.25

3.23

1.7

1.6

278.00

284.21

mosm/kgh2o

0.68

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

304

1.70

3.17

1.4

1.2

248.03

228.71

u/ml

0.27

197

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

124

2.12

3.15

1.3

—

nmol/l

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.97

3.14

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

110

1514

0.71

3.13

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

3.45

3.10

1.3

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.82

3.09

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

985

0.64

3.05

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

133

2.05

3.02

1.1

—

(3022689) Creatine [Moles/volume] in Urine

4.30

2.99

1.1

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.56

2.96

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

397

1.59

2.95

1.7

35.37

39.99

nmol/l

1.05

390

(3042517) Benzodiazepines panel - Urine

4.72

2.92

1.5

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

348

0.43

2.91

1.0

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.45

2.90

1.0

1.1

101.00

95.72

0.28

(3049717) Cytology report of Urine Cyto stain

259

1.72

2.89

3.0

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

200

1.82

2.87

7.4

2.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

2.20

2.84

2.0

2.9

1.13

1.50

g/24h

0.44

(3000093) Morphology [Interpretation] in Blood Narrative

2.41

2.80

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

139

1.96

2.71

1.3

0.60

0.54

nmol/l

0.49

132

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

430

1.53

2.71

1.0

1.1

0.60

4.65

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

113

836

1.38

2.64

1.0

—

(3022621) pH of Urine by Test strip

100

726

1.40

2.61

2.6

2.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

7.16

2.55

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.47

2.54

1.0

1.3

113.83

115.73

ng/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

1.83

2.50

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

178

1420

1.29

2.50

1.9

1.8

—

(3002619) Bacteria identified in Specimen by Culture

3.48

2.48

1.4

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

130

1.94

2.46

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

219

1800

1.25

2.41

2.0

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

1.77

2.40

1.3

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

190

1.75

2.38

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

251

1.65

2.38

1.8

1.5

102.36

106.77

u/ml

0.11

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.62

2.36

1.4

5028.17

18937.37

e6/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.27

2.34

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.83

2.34

2.2

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

254

1.63

2.29

1.3

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.95

2.28

1.4

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.47

2.28

1.4

6719.38

2469.83

e6/l

—

(3045424) Erythrocytes [Presence] in Urine

201

1.71

2.26

1.2

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.11

2.23

1.1

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

2.35

2.22

1.3

1.2

6.34

6.43

mmol/l

0.05

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.70

2.21

2.1

2.0

15.51

15.76

umol/l

0.03

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.14

2.19

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.14

2.19

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.14

2.19

1.1

1.0

—

(3033799) Differential panel - Peritoneal fluid

3.35

2.18

1.5

1.6

—

(3044927) Protein electrophoresis panel - Urine

2.25

2.18

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1.99

2.16

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

1.99

2.16

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1.99

2.16

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1.99

2.16

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1.99

2.16

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

102

1.97

2.10

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.21

2.09

1.9

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

131

1.85

2.08

1.2

1.1

—

(4035726) Immunohistochemistry procedure

113

871

1.32

2.07

1.3

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.91

2.07

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.01

2.07

1.2

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.01

2.07

1.0

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.99

2.05

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

139

1.81

2.05

1.4

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

4.01

2.04

1.7

1.9

—

(3024928) Oxygen saturation in Venous blood

185

1.69

2.02

3.0

2.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.01

2.00

1.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

111

859

1.32

1.99

2.6

2.3

69.97

76.88

ml/min/173m2

0.59

307

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.15

1.98

1.3

1.6

—

(40768806) Pleura Pathology biopsy report

2.29

1.98

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

202

1.65

1.96

1.9

4.82

5.07

mmol/24h

0.18

180

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.76

1.93

4.7

10.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

157

1.73

1.93

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.06

1.91

3.6

2.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.19

1.88

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.19

1.88

1.1

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.32

1.88

1.2

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.32

1.88

1.2

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.87

1.86

3.6

4.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.87

1.86

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.87

1.86

1.4

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

159

1.71

1.86

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.95

1.85

1.5

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

190

1.64

1.85

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

190

1.64

1.85

1.3

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

115

1.84

1.83

1.8

1.6

1.89

1.31

promille

0.71

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.18

1.82

17.8

2.8

4.80

7.60

mmol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

130

1.78

1.82

1.3

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

2.07

1.81

1.3

1.8

—

(3017509) Phencyclidine [Presence] in Urine

3.05

1.80

3.9

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

117

1.81

1.74

2.2

2.8

3.68

51.77

nmol/l

0.50

112

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

147

1.71

1.74

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

2.51

1.66

1.3

2.5

204.00

167.69

e6/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.17

1.66

1.0

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.59

1.66

1.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.11

1.65

1.2

1.1

138.70

180.95

iu/ml

0.51

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.90

1.65

1.2

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1.90

1.65

1.4

242132.50

74122.03

e6/l

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.90

1.65

1.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.90

1.65

1.2

1.7

—

(3014271) Vancomycin [Susceptibility]

2.81

1.65

3.1

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

1.94

1.64

2.4

3.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.98

1.64

3.9

2.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

189

1.60

1.63

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

189

1.60

1.63

1.4

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

286

1.48

1.63

1.2

1.3

3.69

3.63

mmol/l

0.12

269

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1089

10460

1.15

1.62

3.7

3.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

379

1.41

1.60

2.8

2.3

0.68

0.67

0.06

379

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.51

1.59

1.0

2.3

—

(3044007) Cell count panel - Peritoneal fluid

2.70

1.58

2.4

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

1.69

1.55

1.3

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

201

1.55

1.52

1.7

1.8

—

1330.00

—

(3045414) Leukocytes [Presence] in Urine

522

1.34

1.50

1.5

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

170

1.60

1.49

1.3

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.08

1.49

1.0

1.1

—

(3004451) EKG impression Narrative

2.44

1.48

1.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.44

1.48

7.0

3.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.23

1.46

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.38

1.45

1.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.38

1.45

1.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

117

1.72

1.45

1.6

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.12

1.44

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1073

0.78

1.44

1.8

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.20

1.37

1.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.95

1.36

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

112

1.71

1.35

1.3

1.7

—

(3045788) Cell count panel - Pleural fluid

2.15

1.33

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

105

1.72

1.33

1.7

1.8

—

(3011985) Renin [Units/volume] in Plasma

121

1.66

1.31

1.7

1.3

64.80

42.30

mu/l

0.39

106

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.78

1.28

7.2

9.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.01

1.27

1.5

1.1

126.00

77.27

u/l

0.38

(21494814) CD8 cells/100 lymphocytes in Specimen

2.05

1.27

1.0

2.3

—

(3017569) Oxygen content in Arterial blood

2.17

1.21

8.4

3.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.17

1.21

1.6

1.3

143.50

90.64

nmol/l

—

(3044290) Cell count panel - Cerebral spinal fluid

263

1.42

1.21

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

419

1.32

1.19

1.6

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.06

1.15

1.8

1.4

12.19

7.79

ug/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.50

1.15

4.8

7.5

—

(3042733) HLA Ab [Presence] in Serum

2.01

1.12

6.8

4.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

398

1.32

1.11

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

649

1.25

1.09

1.3

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.39

1.09

1.6

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

287

1.37

1.07

1.3

1.4

430.55

1631.86

e6/l

0.62

231

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

287

1.37

1.07

1.2

1.3

71.52

20.21

e6/l

0.54

223

(40768446) Kidney Pathology biopsy report

1.93

1.06

2.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

105

1.63

1.06

1.1

1.0

—

(3035880) pH of Pleural fluid

2.13

1.05

1.4

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

744

0.78

1.05

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

246

1.39

1.04

1.3

4.00

5.25

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.96

1.03

2.8

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.28

1.03

4.8

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.28

1.03

4.8

2.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

122

1.56

1.02

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.69

1.01

1.3

1.2

—

44.67

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

265

1.37

1.00

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

323

2960

1.12

0.99

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.84

0.98

1.3

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

108

1.58

0.96

1.9

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.86

0.96

1.3

1.1

45.50

13.51

u/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

133

1.51

0.94

1.9

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.90

0.94

1.1

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

117

1.54

0.94

1.3

1.4

266.61

412.60

pmol/l

1.73

100

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

346

0.72

0.88

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.67

0.85

1.3

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.94

0.84

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

146

1.44

0.82

1.3

1.5

—

(3024263) Appearance of Synovial fluid

1.74

0.82

2.1

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

223

1.35

0.82

1.2

1.1

115.07

116.67

0.14

204

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.61

0.81

1.3

1.2

—

41.00

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

241

1.33

0.81

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

383

1.26

0.80

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

119

1355

0.87

0.77

2.3

2.5

0.61

0.69

ug/l

0.69

760

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

248

2274

1.11

0.77

3.2

3.8

1.23

1.88

ug/l

3.59

229

2078

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.77

0.76

1.2

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

377

1.25

0.76

1.2

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.76

0.0

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.70

0.75

1.3

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

378

1.25

0.75

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

116

1.47

0.74

1.5

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.00

0.72

7.4

8.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.00

0.72

7.4

8.0

—

(3001556) Androgen free Index in Serum or Plasma

2.00

0.72

1.0

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.80

0.72

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

1.67

0.72

2.6

4.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.58

0.71

1.0

1.5

160.44

177.38

mmol/24h

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.55

0.69

1.0

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.55

0.69

56.3

30.2

8.23

7.44

ug/l

—

(3029075) Extractable nuclear Ab panel - Serum

1.67

0.68

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

307

0.75

0.68

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

241

1.29

0.66

1.4

1.3

3.40

4.13

u/ml

—

106

(3004716) Salmonella sp identified in Stool by Organism specific culture

868

1.15

0.65

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

103

1.46

0.65

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

120

1.42

0.64

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.64

0.62

1.3

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

139

1.37

0.60

1.3

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

139

1.37

0.60

1.3

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

372

1.22

0.59

2.5

2.0

2.71

4.81

iu/l

2.43

151

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

237

1.27

0.58

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.51

0.58

1.3

1.2

—

(3036489) Thrombin time

465

1.19

0.58

1.9

2.2

20.53

20.91

0.33

406

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

346

1.22

0.58

1.4

0.29

0.46

nmol/l

1.57

288

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

668

0.85

0.57

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

297

0.77

0.56

1.2

1.1

17.10

4.33

u/ml

0.64

141

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.57

0.56

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

320

1.22

0.56

1.9

2.3

9.60

4.72

umol/l

0.57

236

(3002523) Influenza virus A Ag [Presence] in Specimen

307

0.78

0.55

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

273

0.77

0.55

1.1

11.38

5.55

u/ml

—

109

(3036071) Salmonella sp Ab [Titer] in Serum

1.48

0.53

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

100

1.40

0.52

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.47

0.50

4.1

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.42

0.50

4.6

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

279

1.22

0.50

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

126

1146

1.11

0.50

1.2

137.61

160.33

iu/ml

0.22

456

(3045142) Bone marrow Pathology biopsy report

108

0.65

0.48

1.0

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.52

0.48

1.1

2.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

332

0.81

0.47

1.2

1.1

3.53

2.28

u/ml

0.27

157

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

173

1.28

0.46

1.2

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

579

0.86

0.46

1.3

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

119

0.67

0.45

1.3

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.43

0.45

3.2

3.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.37

0.44

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

461

1.16

0.43

2.1

2.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

230

1.22

0.42

1.2

1.4

7.22

7.10

mmol/l

0.08

209

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.43

0.42

1.3

256.63

482.92

u/l

—

(3008037) Lactate [Moles/volume] in Venous blood

158

1.27

0.42

2.5

2.7

1.45

1.46

mmol/l

0.04

153

(3025577) Chromium [Mass/volume] in Blood

1.52

0.41

2.0

2.1

1.60

1.90

ug/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.36

0.41

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

168

1.25

0.40

1.3

1.1

99.52

95.02

0.41

160

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.40

0.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.39

0.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.39

0.0

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

252

1.19

0.38

1.1

1.0

1.86

2.12

u/ml

0.15

128

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.35

0.38

1.4

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.43

0.35

2.7

1.2

12.07

13.14

pmol/l

—

(21494434) Karyotype in Bone marrow

0.63

0.35

1.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.37

0.34

3.7

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

283

1.17

0.34

1.6

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.33

0.33

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.33

0.32

1.5

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

101

1.29

0.31

1.2

1.0

0.94

1.06

u/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.32

0.31

1.0

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

129

1.24

0.30

1.2

1.0

—

(3011648) Oxygen content in Venous blood

1.34

0.30

3.0

2.0

9.10

11.38

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

241

1.16

0.29

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

111

0.72

0.28

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

216

0.83

0.28

1.6

7.60

7.69

mmol/l

0.06

208

(3039443) Prostate specific Ag panel - Serum or Plasma

215

0.84

0.27

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

279

0.86

0.27

1.9

1.8

—

(40768795) Lymph node Pathology biopsy report

104

1.25

0.26

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

1.19

0.25

1.4

1.5

—

(4034850) Laboratory test

382

0.89

0.25

10.6

8.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

180

1.17

0.23

3.9

3.8

25.57

24.84

u/ml

0.03

175

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.27

0.22

1.0

1.1

—

9.71

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

295

1.12

0.22

2.2

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.22

0.22

1.2

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.22

0.22

1.2

2.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

1.1

0.11

8.21

u/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

202

2097

0.96

0.21

1.7

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.19

0.21

1.2

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.21

0.0

1.7

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

3.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

3.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

201

1.15

0.21

2.3

3.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

3.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3024932) HLA-DR beta [Type]

1.16

0.21

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.21

0.0

1.0

—

(3003338) MCHC [Mass/volume]

1150

11589

0.97

0.20

25.3

13.2

331.50

333.27

g/l

8.94

1143

11502

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.23

0.20

1.2

—

(3023410) Appearance of Cerebral spinal fluid

128

1.17

0.18

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

188

1818

1.04

0.17

3.1

3.5

23.20

21.13

0.64

700

(1761868) Lipid panel - Serum or Plasma

516

5248

0.97

0.17

2.9

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

660

0.94

0.17

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.80

0.14

2.7

2.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.18

0.14

1.1

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.78

0.14

2.7

2.4

104.71

105.91

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

0.78

0.14

2.7

2.4

3.83

3.93

mmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

262

2563

1.03

0.13

1.7

—

(3020650) Glucose [Presence] in Urine

1.14

0.10

2.0

1.4

—

(3024471) HLA-A [Type]

1.14

0.10

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.11

0.09

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.83

0.08

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.78

0.08

1.0

1.2

—

(40768793) Breast Pathology biopsy report

303

1.06

0.08

1.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

392

1.05

0.07

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

235

1.06

0.07

4.2

3.3

21.77

24.80

mg/l

0.23

149

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.03

0.07

1.1

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

167

1.08

0.07

2.4

2.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.87

0.06

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

329

1.03

0.03

1.0

1.1

3.11

1.89

u/ml

0.27

128

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

653

0.98

0.03

1.7

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

381

0.97

0.03

1.2

1.1

1.06

2.84

u/ml

1.47

190

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

189

0.95

0.03

1.2

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

351

1.03

0.02

1.1

9.91

5.62

u/ml

0.47

178

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.08

0.02

5.7

2.9

40.48

62.26

u/ml

—

(4281824) Cell count and differential, peritoneal fluid

113

1.06

0.02

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

123

1.06

0.01

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.06

0.01

1.3

1.4

140.96

163.75

pmol/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

184

1.03

0.00

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

204

0.98

0.00

2.8

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

258

1.01

0.00

1.4

1.1

—

(3003694) ABO and Rh group [Type] in Blood

420

4204

1.00

0.00

1.5

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

107

1.03

0.00

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

133

0.98

0.00

1.2

1.7

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

2.7

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.3

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.98

-0.00

1.8

2.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

-0.00

0.0

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.93

-0.00

1.3

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

4.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.01

-0.00

1.6

1.8

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.85

-0.00

1.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

2.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_HIDRADENITISSUP and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_HIDRADENITISSUP	2.542 [2.09, 3.09]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.08

During the follow-up period (1.1.1998 — 31.12.2019), 168 out of 3437 females with L12_HIDRADENITISSUP died.

Males

Parameter	HR [95% CI]	p-value
L12_HIDRADENITISSUP	2.558 [2.19, 2.99]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 286 out of 2336 males with L12_HIDRADENITISSUP died.

Mortality risk

Mortality risk for people of age

years, who have L12_HIDRADENITISSUP.

N-year risk	Females	Males
1	0.225%	0.52%
5	1.414%	2.929%
10	3.201%	7.481%
15	6.359%	14.047%
20	11.188%	22.631%

Relationships between endpoints

↥

Index endpoint: L12_HIDRADENITISSUP – Hidradenitis suppurativa

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hidradenitis suppurativa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints